◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Spectral Medical Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 675,000 813,000 572,000 645,000 502,000 --
Operating Revenue 675,000 813,000 572,000 645,000 502,000 --
Cost Of Revenue 191,000 291,000 125,000 274,000 88,000 --
Gross Profit 484,000 522,000 447,000 371,000 414,000 --
Selling General And Administration 2.9M 2.8M 3.7M 2.7M 2.8M --
General And Administrative Expense 2.9M 2.8M 3.7M 2.7M 2.8M --
Depreciation And Amortization In Income Statement 53,000 26,000 41,000 60,000 51,000 --
Other Operating Expenses 619,000 234,000 348,000 157,000 713,000 --
Operating Expense 3.6M 3.0M 4.1M 2.9M 3.5M --
Operating Income -3.1M -2.5M -3.7M -2.5M -3.1M --
EBIT -29.0M -758,000 -11.5M 4.2M -9.0M --
Interest Expense 1.4M 1.2M 1.1M 999,000 970,000 --
Interest Expense Non Operating 1.4M 1.2M 1.1M 999,000 970,000 --
Net Interest Income 888,000 2.0M -1.1M -999,000 -970,000 --
Other Income Expense -28.1M -1.4M -7.8M 6.7M -5.9M --
Other Non Operating Income Expenses -46,000 -57,000 -59,000 -40,000 -163,000 --
Gain On Sale Of Security -28.0M -1.3M -7.8M 6.7M -5.8M --
Earnings From Equity Interest -- -- -- 0.00 0.00 0.00
Pretax Income -30.3M -1.9M -12.6M 3.2M -10.0M --
Tax Effect Of Unusual Items 0.00 0.00 0.00 1.0M 0.00 --
Net Income From Continuing And Discontinued Operation -30.3M -1.9M -12.6M 3.2M -10.0M --
Net Income From Continuing Operation Net Minority Interest -30.3M -1.9M -12.6M 3.2M -10.0M --
Net Income Including Noncontrolling Interests -30.3M -1.9M -12.6M 3.2M -10.0M --
Net Income Common Stockholders -30.3M -1.9M -12.6M 3.2M -10.0M --
Net Income -30.3M -1.9M -12.6M 3.2M -10.0M --
EBITDA -28.9M -701,000 -11.5M 4.2M -9.0M --
Normalized EBITDA -859,000 642,000 -3.7M -2.5M -3.2M --
Reconciled Depreciation 69,000 57,000 60,000 61,000 63,000 --
Basic EPS -0.11 0.00 -0.04 -- -0.04 -0.02
Diluted EPS -0.11 0.00 -0.04 -- -0.04 -0.02
Basic Average Shares 287.0M 284.9M 284.8M -- 281.7M 280.0M
Diluted Average Shares 287.0M 284.9M 284.8M -- 281.7M 280.0M
Total Unusual Items -28.0M -1.3M -7.8M 6.7M -5.8M --
Total Unusual Items Excluding Goodwill -28.0M -1.3M -7.8M 6.7M -5.8M --
Tax Rate For Calcs 0.00 0.00 0.00 0.15 0.00 --
Normalized Income -2.3M -590,000 -4.8M -2.6M -4.2M --
Depreciation Amortization Depletion Income Statement 53,000 26,000 41,000 60,000 51,000 --
Diluted NI Availto Com Stockholders -30.3M -1.9M -12.6M 3.2M -10.0M --
Insurance And Claims 98,000 82,000 101,000 105,000 105,000 --
Net Income Continuous Operations -30.3M -1.9M -12.6M 3.2M -10.0M --
Net Income Discontinuous Operations 0.00 0.00 -3,000 -4,000 0.00 --
Net Non Operating Interest Income Expense 888,000 2.0M -1.1M -999,000 -970,000 --
Other Gand A 1.5M 1.3M 1.3M 1.4M 1.3M --
Reconciled Cost Of Revenue 175,000 260,000 106,000 273,000 76,000 --
Salaries And Wages 1.4M 1.3M 2.3M 1.2M 1.3M --
Total Expenses 3.8M 3.3M 4.3M 3.2M 3.6M --
Total Other Finance Cost -2.3M -3.1M -- -- -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 5.9M 3.1M 1.7M 3.0M 5.8M --
Cash Cash Equivalents And Short Term Investments 5.9M 3.1M 1.7M 3.0M 5.8M --
Cash Financial 5.9M 3.1M 1.7M 3.0M 5.8M --
Accounts Receivable 433,000 306,000 310,000 300,000 337,000 --
Receivables 433,000 306,000 310,000 451,000 337,000 --
Inventory 218,000 244,000 201,000 229,000 318,000 --
Prepaid Assets -- -- -- 790,000 -- --
Other Current Assets 711,000 934,000 1.1M -- 882,000 932,000
Current Assets 7.3M 4.6M 3.3M 4.5M 7.3M --
Gross PPE 524,000 578,000 631,000 4.3M 743,000 --
Accumulated Depreciation -- -- -- -3.6M -- --
Net PPE 524,000 578,000 631,000 687,000 743,000 --
Goodwill And Other Intangible Assets 347,000 334,000 171,000 175,000 180,000 --
Other Intangible Assets -- -- -- 175,000 -- --
Investments And Advances -- -- -- 0.00 0.00 --
Long Term Equity Investment -- -- -- 0.00 0.00 --
Total Non Current Assets 871,000 912,000 802,000 862,000 923,000 --
Total Assets 8.1M 5.5M 4.1M 5.3M 8.2M --
Current Debt 16.1M 14.9M 14.8M 14.4M 12.9M --
Current Debt And Capital Lease Obligation 16.2M 15.0M 14.9M 14.6M 13.0M --
Accounts Payable 3.0M 3.2M 4.3M 990,000 3.0M --
Payables 3.0M 3.2M 4.3M 1.2M 3.0M --
Payables And Accrued Expenses 3.0M 3.2M 4.3M 2.8M 3.0M --
Current Accrued Expenses -- -- -- 1.5M -- --
Current Deferred Revenue 759,000 510,000 720,000 380,000 502,000 --
Other Current Liabilities 47.4M 19.5M 17.5M 9.7M 17.4M --
Current Liabilities 67.4M 38.3M 37.5M 27.4M 33.9M --
Long Term Debt 4.5M 2.3M -- -- -- 12.2M
Long Term Debt And Capital Lease Obligation 4.7M 2.6M 338,000 371,000 404,000 --
Long Term Capital Lease Obligation 270,000 304,000 338,000 371,000 404,000 --
Total Non Current Liabilities Net Minority Interest 9.4M 7.4M 5.3M 5.4M 5.6M --
Total Liabilities Net Minority Interest 76.8M 45.7M 42.8M 32.9M 39.5M --
Common Stock 93.8M 91.2M 90.9M 90.6M 89.9M --
Capital Stock 93.8M 91.2M 90.9M 90.6M 89.9M --
Additional Paid In Capital 10.1M 10.1M 10.1M 10.1M 10.1M --
Retained Earnings -185.7M -155.4M -153.4M -140.8M -144.0M --
Common Stock Equity -68.7M -40.2M -38.7M -27.5M -31.3M --
Stockholders Equity -68.7M -40.2M -38.7M -27.5M -31.3M --
Total Equity Gross Minority Interest -68.7M -40.2M -38.7M -27.5M -31.3M --
Total Capitalization -64.2M -37.9M -38.7M -27.5M -31.3M --
Net Tangible Assets -69.0M -40.5M -38.9M -27.7M -31.5M --
Tangible Book Value -69.0M -40.5M -38.9M -27.7M -31.5M --
Working Capital -60.1M -33.7M -34.3M -23.0M -26.6M --
Invested Capital -48.1M -23.0M -23.9M -13.1M -18.4M --
Total Debt 21.0M 17.6M 15.3M 14.9M 13.4M --
Net Debt 14.7M 14.1M 13.1M 11.4M 7.1M --
Share Issued 289.1M 285.8M 285.1M 284.3M 282.8M --
Ordinary Shares Number 289.1M 285.8M 285.1M 284.3M 282.8M --
Allowance For Doubtful Accounts Receivable -- -- -- 0.00 -- --
Capital Lease Obligations 404,000 436,000 468,000 500,000 530,000 --
Current Capital Lease Obligation 134,000 132,000 130,000 129,000 126,000 --
Current Deferred Liabilities 759,000 510,000 720,000 380,000 502,000 --
Current Notes Payable 16.1M 14.9M 14.8M 14.4M 12.9M --
Finished Goods -- -- -- 105,000 -- --
Gross Accounts Receivable -- -- -- 300,000 -- --
Investmentsin Associatesat Cost -- -- -- 0.00 0.00 --
Leases -- -- -- 392,000 -- --
Machinery Furniture Equipment -- -- -- 1.8M -- --
Non Current Deferred Liabilities 4.7M 4.8M 4.9M 5.0M 5.2M --
Non Current Deferred Revenue 4.7M 4.8M 4.9M 5.0M 5.2M --
Other Current Borrowings -- -- -- -- -- 334,000
Other Equity Interest 13.1M 13.9M 13.7M 12.6M 12.7M --
Other Payable -- -- -- 257,000 -- --
Other Properties 524,000 578,000 631,000 2.0M 743,000 --
Other Receivables -- -- -- 134,000 -- --
Properties -- -- -- 0.00 -- --
Raw Materials -- -- -- 118,000 -- --
Taxes Receivable -- -- -- 17,000 -- --
Work In Process -- -- -- 6,000 -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -2.7M -2.7M -1.4M -2.3M -2.9M --
Cash Flow From Continuing Operating Activities -2.7M -2.7M -1.4M -2.3M -2.9M --
Depreciation And Amortization 69,000 57,000 60,000 61,000 63,000 --
Depreciation Amortization Depletion 69,000 57,000 60,000 61,000 63,000 --
Stock Based Compensation 336,000 307,000 1.3M 178,000 241,000 --
Change In Working Capital 8,000 -564,000 919,000 -203,000 -113,000 --
Change In Receivables -127,000 4,000 141,000 -114,000 15,000 --
Change In Inventory 26,000 -43,000 28,000 89,000 -46,000 --
Change In Payables And Accrued Expense -241,000 -339,000 820,000 -27,000 12,000 --
Change In Payable -241,000 -339,000 820,000 -27,000 12,000 --
Change In Other Working Capital 127,000 -331,000 219,000 -243,000 -144,000 --
Other Non Cash Items -807,000 -1.9M 1.1M 1.0M 1.2M --
Capital Expenditure -28,000 -- -- -- -4,000 -8,000
Purchase Of PPE 0.00 0.00 0.00 1,000 -4,000 --
Net PPE Purchase And Sale 0.00 0.00 0.00 1,000 -4,000 --
Investing Cash Flow -28,000 -167,000 0.00 1,000 -4,000 --
Cash Flow From Continuing Investing Activities -28,000 -167,000 0.00 1,000 -4,000 --
Issuance Of Debt 4.2M -- -- 0.00 1.4M --
Repayment Of Debt -56,000 -22,000 -38,000 -38,000 -39,000 --
Net Issuance Payments Of Debt 4.1M 5.5M -38,000 -38,000 1.3M --
Financing Cash Flow 5.5M 4.3M 116,000 -477,000 1.1M --
Cash Flow From Continuing Financing Activities 5.5M 4.3M 116,000 -477,000 1.1M --
Changes In Cash 2.8M 1.4M -1.3M -2.8M -1.8M --
Beginning Cash Position 3.1M 1.7M 3.0M 5.8M 7.5M --
End Cash Position 5.9M 3.1M 1.7M 3.0M 5.8M --
Free Cash Flow -2.7M -2.9M -1.4M -2.3M -2.9M --
Amortization Cash Flow 15,000 4,000 4,000 5,000 4,000 --
Amortization Of Intangibles 15,000 4,000 4,000 5,000 4,000 --
Cash Dividends Paid 0.00 -- -- 0.00 0.00 --
Change In Prepaid Assets 223,000 145,000 -289,000 92,000 50,000 --
Depreciation 54,000 53,000 56,000 56,000 59,000 --
Gain Loss On Investment Securities 27.5M 2.9M 7.8M -8.5M 6.2M --
Gain Loss On Sale Of Business -- -- -- 0.00 0.00 0.00
Interest Paid Cff -102,000 -- -- -455,000 -276,000 --
Long Term Debt Issuance 4.2M -- -- 0.00 1.4M --
Long Term Debt Payments -56,000 -22,000 -38,000 -38,000 -39,000 --
Net Foreign Currency Exchange Gain Loss 571,000 -1.6M -26,000 2.0M -461,000 --
Net Income From Continuing Operations -30.3M -1.9M -12.6M 3.2M -10.0M --
Net Intangibles Purchase And Sale -28,000 -- -- -- 0.00 --
Net Long Term Debt Issuance 4.1M 5.5M -38,000 -38,000 1.3M --
Net Other Financing Charges -5,000 -- -- 0.00 -44,000 --
Operating Gains Losses 28.0M 1.3M 7.8M -6.5M 5.7M --
Proceeds From Stock Option Exercised 1.5M 186,000 154,000 16,000 124,000 --
Purchase Of Intangibles -28,000 -- -- -- 0.00 --
NEWS
Loading news...
TRENDING
Loading...